Background: The purpose of this study was to determine the dose-response association between habitual physical activity (PA) and cognitive function using a nationally representative data set of U.S. older adults aged ≥60 years.
Methods: We used data from the 2011-2014 National Health and Nutrition Examination Survey (n = 2 441, mean [SE] age: 69.1 [0.2] years, 54.7% females). Cognitive function was assessed using the digit symbol substitution test (DSST) and animal fluency test (AFT). Habitual PA was collected using a triaxial accelerometer worn on participants' nondominant wrist. PA was expressed as 2 metrics using monitor-independent movement summary (MIMS) units: the average of Daily MIMS (MIMS/day) and peak 30-minute MIMS (Peak-30MIMS; the average of the highest 30 MIMS min/d). Sample weight-adjusted multivariable linear regression was performed to determine the relationship between each cognitive score and MIMS metric while adjusting for covariates.
Results: After controlling for covariates, for each 1 000-unit increase in Daily MIMS, DSST score increased (β-coefficient [95% CIs]) by 0.67 (0.40, 0.93), whereas AFT score increased by 0.13 (0.04, 0.22); for each 1-unit increase in Peak-30MIMS, DSST score increased by 0.56 (0.42, 0.70), whereas AFT score increased by 0.10 (0.05, 0.15), all p < .001. When including both MIMS metrics in a single model, the association between Peak-30MIMS and cognitive scores remained significant (p < .01), whereas Daily MIMS did not.
Conclusions: Our findings suggest that higher PA (both daily accumulated and peak effort) is associated with better cognitive function in the U.S. older adult population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/gerona/glac076 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Daily and Peak Monitor Independent Movement Summary (MIMS) Values Associated With Metabolic Syndrome: NHANES 2011-12 and 2013-14.
Scand J Med Sci Sports
November 2024
Department of Kinesiology, California State University Long Beach, Long Beach, California, USA.
The U.S. National Health and Nutrition Examination Survey (NHANES) physical activity monitor datasets for 2011-12 and 2013-14 were released in late 2020.
View Article and Find Full Text PDFValproate-induced hyperammonemic encephalopathy in neurosurgical patients: Our experience and systematic literature review.
Neurosurg Rev
November 2024
Department of Neurosurgery, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
Article Synopsis
- Sodium valproate is commonly used to treat seizures, chronic pain, and bipolar disorder, but it can cause severe side effects like valproate-induced hyperammonemic encephalopathy (VHE), which is life-threatening.
- A study reviewed four neurosurgical patients who developed VHE after using valproate for seizure prevention, revealing a 50% mortality rate and indicating that prompt diagnosis and treatment are crucial.
- Treatment involved discontinuing valproate and, in some cases, dialysis; half of the patients experienced clinical improvement after normalization of ammonia levels.
Role of dietary potassium and salt substitution in the prevention and management of hypertension.
Hypertens Res
January 2025
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Cardiovascular diseases (CVD) continue to be the leading cause of deaths and disability worldwide and the major contributor is hypertension. Despite all the improvements in detecting hypertension together with technological advances and affordable, efficacious and relatively free of adverse effects anti-hypertensive agents, we continue to struggle to prevent the onset of hypertension and to control blood pressure (BP) to acceptable targets. The poor control of hypertension is commonly due to non-adherence to medications.
View Article and Find Full Text PDFHer2 positive metastatic breast cancer treated with low dose lapatinib in a resource-constrained setting in South India: a retrospective audit.
Ecancermedicalscience
September 2024
Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kerala 670103, India.
Article Synopsis
- Newer anti-Her2 medications are limited in access, leading to the prevalent use of lapatinib, which has a high financial burden for patients in low-income areas.
- A study in South India tested a low-dose lapatinib regimen (500 mg daily with meals) on patients who couldn't afford standard treatments, showing promising disease control rates and manageable toxicity.
- Among 47 patients, the disease control rate was 61.7% with a median progression-free survival of 7 months, indicating low-dose lapatinib could be a viable option in resource-constrained settings.
Determining the relationship of p16 and additional molecular markers of aging with clinical frailty in hematologic malignancy.
J Cancer Surviv
August 2024
Departments of Molecular Genetics, Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Purpose: Older adults with hematologic malignancies (HM) have unique challenges due to age and fitness. The primary aim of this pilot study was to benchmark the ability of multiple biomarkers of aging (p16, epigenetic clocks, T cell gene expression profiles, and T cell receptor excision circles (TREC) to identify frailty as measured by a clinical impairment index (I) in patients with HM.
Methods: 70 patients newly diagnosed with HM had peripheral blood T lymphocytes (PBTL) analyzed for p16 expression using the OSU_Senescence Nanostring CodeSet.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!